The ligand-dependent degradation of activated tyrosine kinase receptors provides a means by which mitogenic signalling can be attenuated. In many cell types the ligand-dependent degradation of the tyrosine kinase receptor Met is completely dependent on the activity of the 26S proteasome (Jeers et al., 1997b) . We now show that degradation also requires tracking to late endosomal compartments and the activity of acid dependent proteases as determined by the eects of a dominant negative form of dynamin (K44A) and a vacuolar-ATPase inhibitor, concanamycin. We show that in the presence of the proteasome inhibitor lactacystin, Met fails to redistribute from the plasma membrane to intracellular compartments. This observation is most consistent with the interpretation that proteasome activity is required for Met internalization and only indirectly for its degradation. Oncogene (2001) 20, 2761 ± 2770.
Introduction
Growth factor receptors endowed with intrinsic tyrosine activity play a central role in the control of proliferation in both normal and neoplastic cells. The product of the met proto-oncogene is one such receptor tyrosine kinase (RTK) which has been identi®ed as the high anity receptor for hepatocyte growth factor/scatter factor (HGF/SF) (Bottaro et al., 1991; Naldini et al., 1991) . Met was ®rst identi®ed as the product of a human oncogene, tpr-met, which represents the fusion of two distinct genetic loci: tpr, which contributes a protein ± protein dimerization motif, and met, which contributes the intracellular portion of the Met receptor containing the kinase domain. The resultant chimeric fusion protein generated from tpr-met is dimerized and activated in the absence of ligand and therefore possesses constitutive kinase activity and transforming ability (Cooper et al., 1984; Park et al., 1986; Rodrigues and Park, 1993) .
HGF/SF is a multifunctional cytokine predominantly produced in cells of mesenchymal origin. Under normal physiological conditions, HGF/SF can regulate not only cellular proliferation and growth (that is, mitogenesis'), but also cellular motility (`motogenesis') and shape (`morphogenesis'), depending on the target cell type (reviewed in Jeers et al., 1996; Rubin et al., 1993; Van der Voort et al., 2000) . Aberrant HGF/SFMet signalling is implicated in the generation and spread of tumours and metastases (reviewed by Jeers et al., 1996) . In addition to tpr-met, several other oncogenic forms of Met have been identi®ed and it is becoming increasingly apparent that understanding the cell biology of the HGF/SF-Met system is of great importance in elucidating the development and progression of human cancer (Jeers et al., 1997a) .
Growth factor binding to RTKs triggers receptor autophosphorylation and/or phosphorylation of additional intracellular substrates. Such signalling events are rapid and serve to transduce signals from the cell surface to the necessary cytoplasmic and nuclear targets. In several well-studied cases, such as the Epidermal Growth Factor (EGF) receptor and Platelet Derived Growth Factor (PDGF) b-receptor, ligandbinding also triggers events leading to receptor-ligand internalization through clathrin-coated vesicles (CCVs) in a process referred to as receptor-mediated endocytosis. This rapid removal of growth factor receptors from the cell surface and subsequent targeting to degradative compartments provides a`down-regulation' mechanism important for preventing sustained stimulation which could potentially lead to cellular transformation (Di Fiore and Gill, 1999; Wells et al., 1990) . Internalized receptors follow the classically described pathway for turnover of plasma membrane proteins ± from early endosomes through multivesicular bodies to lysosomes (reviewed in Clague, 1998) . In these cases degradation can be blocked by inhibition of the vacuolar-ATPase that generates the acidic environment necessary for lysosomal enzymes to function or by dissipation of the pH gradient with weak bases.
It has recently become apparent that for some receptors ubiquitination plays a role in their endosomal tracking. Several yeast receptors and transporters (e.g. the a-factor receptor [Ste2p/] and the Uracil permease [Fur4p]), require ubiquitination as a targeting signal for endocytosis and subsequent degradation (reviewed in Hicke, 1999) . Indeed in yeast, all endogenous proteins that are known to be internalized, use ubiquitin as an internalization signal. For certain receptors (e.g. the a-factor receptor) monoubiquitination alone is sucient to signal internalization (Terrel et al., 1998) . Such a modi®cation is distinct from that required for targeting to and degradation by proteasomes, where polyubiquitination resulting in a chain of at least four ubiquitin molecules is required (Chau et al., 1989; Deveraux et al., 1994) .
A number of mammalian receptors, including EGF receptor (Galcheva-Gargova et al., 1995) , PDGF breceptor (Mori et al., 1992) , c-kit receptor (Miyazawa et al., 1994) , T-cell receptor (TCR) (Hou et al., 1994) and Met (Jeers et al., 1997b) have been shown to be polyubiquitinated following ligand stimulation. In the case of EGF receptor, degradation can be mediated by the proto-oncogene cbl; an E3 ubiquitin ligase that has been proposed to act on the receptor at the early endosome where it promotes sorting to multivesicular bodies at the expense of recycling (Lefkowitz et al., 1998) . An important issue is whether modi®cation of receptors with ubiquitin can lead to receptor degradation by targeting to 26S proteasomes. TCR and c-kit degradation following stimulation are both insensitive to proteasome inhibitors (Bonifacino and Weissman, 1998) whilst with PDGFRb 520% inhibition is observed (Mori et al., 1995a,b) .
Met provides an instance where an absolute dependence on proteasome activity for ligand-dependent receptor down-regulation has been shown (Jeers et al., 1997b) . The Met receptor is initially synthesized as a partially glycosylated 170 kDa single-chain intracellular precursor (Giordano et al., 1989) . Following additional glycosylation it is cleaved yielding a mature, cell surface-associated disulphide-linked heterodimer of 190 kDa. This consists of an entirely extracellular a-chain (50 kDa) and a membrane-spanning b-chain (140 kDa) which possesses intrinsic, ligand-activated tyrosine kinase activity in its intracellular C-terminal domain. Upon binding HGF/SF, the b-chain of Met is rapidly polyubiquitinated and degraded in a proteasome-dependent manner (Jeers et al., 1997b) .
In this paper we con®rm the results of Jeers et al. (1997b) that Met degradation is fully sensitive to proteasome inhibition in HeLa cells. However, we also show that a substantial proportion of Met degradation can be inhibited following alkalinization of the endocytic pathway or by blocking endocytosis. Our data suggests that the primary eect of proteasome inhibition on Met degradation occurs indirectly through an eect on Met endocytic tracking. Met is degraded in a time-dependent manner, with less than 10% of control level remaining after 4 h of stimulation ( Figure 1 ). As expected, the level of p170
Results

HGF/SF-induced Met down-regulation/degradation
Met is unaected by HGF/SF stimulation throughout the 4 h period.
Down-regulation/degradation of Met is dependent on both the proteasome and the endosomal/lysosomal system Jeers et al. (1997b) demonstrated that Met is rapidly polyubiquitinated in response to ligand and subsequently down-regulated in a proteasome-dependent manner. In agreement with this work, we also ®nd that ligand-induced degradation of Met is almost entirely prevented by incubating HeLa cells in media containing lactacystin (Figure 2 ; P50.05).
Ligand-activated membrane receptors are typically endocytosed in CCVs and directed towards the endosomal system where a progressively acidic environment provides ideal conditions for lumenal, aciddependent proteases. Even ubiquitinated receptors are degraded via this system (reviewed in Bonifacino and Weissman, 1998) . In order to investigate whether there is an endosomal/lysosomal component to degradation of Met receptor, we repeated the down-regulation assay incubating the cells in media containing the vacuolar ATPase proton-pump inhibitor, concanamy- cin, instead of lactacystin. Met was also partially stabilized by concanamycin, albeit to a lesser extent than by lactacystin ( Figure 2 ). Incubation with HGF/ SF and concanamycin also resulted in the generation of partially degraded forms of Met receptor (see asterisk in Figure 2b ). This band is a doublet and runs at approximately 100 kD on the gel. It is detected using anti-Met Hu extracellular domain antibody but not with an antibody against the intracellular domain.
Inhibition of CCV-mediated endocytosis dramatically reduces the rate of ligand-induced Met down-regulation
We next addressed the question as to whether or not the activated Met receptor has to be internalized into the cell in order to be degraded. We performed the down-regulation assay with cells held at 48C, under which condition membrane trac is arrested. No receptor degradation was observed (data not shown). Next, we employed a stably transfected HeLa cell line (K44A cells) in which regulated expression of a dominant negative (K44A) mutant form of the GTPase dynamin allows a speci®c block of CCV-mediated endocytosis (Damke et al., 1994; van der Bliek et al., 1993) . When cultured in the absence of tetracycline, these cells express K44A mutant dynamin; under these conditions they no longer down regulate EGF receptor (Vieira et al., 1996) .
Lysates from control (+tet) and mutant dynamin expressing (7tet) K44A cells that had been treated with HGF/SF for various lengths of time were examined by Western blotting using anti Met (Figure 3b ) revealed a parallel increase in the generation of *100 kDa degradation products, like those seen with concanamycin co-incubation in wild-type HeLa cells (Figure 2b and 3b, see asterisk). Similar results were obtained using a cruder method of inhibiting CCV-mediated endocytosis, that of incubating HeLa cells in hyperosmotic medium (Heuser and Anderson, 1989 ) (data not shown).
After 1 h of HGF/SF stimulation we observed reduced degradation in those cells expressing K44A mutant dynamin (7Tet), (compare column b in Figure  4A ,B). It is also apparent that degradation in the 7Tet cells is still partially sensitive to lactacystin, but not to concanamycin (compare b with c and d between Figure  4A ,B). Hence in cells speci®cally unable to take-up material via CCV-mediated endocytosis, there is no signi®cant eect of concanamycin. Lactacystin still partially stabilizes activated Met molecules (column d, Figure 4B ; P50.05). It is interesting to note that in this cell line only expressing endogenous wild-type dynamin (+Tet), co-incubation with both lactacystin and concanamycin still does not fully prevent ligandinduced degradation (column e, Figure 4A ; P50.005), in distinction to the HeLa cells that we have used elsewhere in this study.
Met receptor is internalized following stimulation with HGF/SF
In order to visualize the dynamics of ligand-induced Met degradation we carried-out immuno¯uorescence studies using anti Met Hu intracellular domain antibody. In the absence of ligand, Met is primarily localized at the plasma membrane (Figure 5a, panel a) . However, a weak¯uorescent signal is evident at intracellular locations, which may represent Met molecules within the biosynthetic secretory pathway.
Upon binding HGF/SF, the activated Met receptor is rapidly internalized. Fifteen minutes following addition of ligand, distinct punctae reminiscent of early endosomes can be seen (Figure 5a, panel b) . Following the fate of internalized Met molecules over a course of 2 h we observe that, with time, Met accumulates in a peri-nuclear region of the cell in congruence with a progression from early endosomes to late endosomes/lysosomes (Figure 5a , panels c and d). We conducted co-localization studies to con®rm that Met transits through early endosomes as de®ned by the presence of the marker, Early Endosomal Autoantigen 1 (EEA1) (Mu et al., 1995) . Co-localization with EEA1 is clearly evident following 15 min of HGF stimulation (Figure 5b , panels a and b) and is then lost at later time points (not shown). Instead, some Met receptor is found co-localized with lyso-bisphosphatidic acid (LBPA) an established marker of late endosomes (Figure 5b , panels c and d) (Kobyashi et al., 1998) . Co-localization at these later time points is problematic due to the fact that receptor degradation occurs leading to a substantial loss of the C-terminal epitope recognized by the Met antibody in the relevant late endosomal compartment.
Internalization of activated Met molecules is prevented by inhibition of the proteasome
Having established that upon binding HGF/SF, Met is rapidly internalized into the endocytic system ( Figure  5 ) and that ligand-induced down-regulation is dependent on proteasome activity and the endosomal/ lysosomal system (Figure 2) , we next investigated whether there is a relationship between proteasome activity and internalization. Incubation for 1 h in the presence of HGF/SF results in abundant¯uorescent label in endosomal/lysosomal compartments ( Figure 6 , panel a). In contrast, upon co-incubation with lactacystin, little intracellular endosomal/lysosomal staining can be observed. Instead, Met presented a homogenous plasma membrane pattern of staining, similar to that seen in the absence of ligand (Figure 6b , compare with Figure 5a , panel a). Lactacystin does not impose a general block upon receptor-mediated endocytosis, as it does not aect uptake of either biotinylated-transferrin (Figure 6e,f) or of EGF receptor following ligand stimulation (Figure 6c,d) . In summary, our results demonstrate that HGF/SFinduced internalization of Met is dependent on proteasome activity in contrast to other receptors we have looked at.
Discussion
In this study we have con®rmed the ®ndings of Jeers et al. (1997b) that endogenous Met down-regulation is exquisitely sensitive to inhibition of proteasome activity by agents such as lactacystin. As the Met receptor, itself, is ubiquitinated following ligand stimulation, it was proposed that this modi®cation targeted the receptor for destruction by the 26S proteasome. It is not apparent how a plasma membrane protein might be extruded for full destruction by the proteasome, although the proteasome dependent degradation of endoplasmic reticulum membrane proteins has been characterized (reviewed in Bonifacino and Weissman, 1998 ).
An alternative and well established degradation route of tyrosine kinase receptors is that of lysosomal degradation following internalization via clathrin coated vesicles and sorting to multivesicular bodies (reviewed in Clague, 1998) . The contribution of this pathway can be analysed by using reagents that alkalinize endocytic compartments such that degradative enzymes are inactive. We have used concanamycin, a speci®c inhibitor of the v-ATPase proton pump that is responsible for endosome acidi®cation. A close analogue of concanamycin, ba®lomycin, has previously been shown to block EGF receptor degradation (Yoshimori et al., 1991) . Surprisingly, we also obtained signi®cant inhibition of Met degradation following a concanamycin treatment. This result demonstrates that the proteasomal and lysosomal degradation pathways for Met must largely overlap and be mutually dependent.
We next examined ligand-dependent Met degradation under conditions where clathrin-mediated endocytosis had been blocked, either crudely using hypertonic media, or more speci®cally by inducing the expression b Figure 2 Evidence of an involvement of the ubiquitin-proteasome system and the endosomal/lysosomal system in HGF/SFinduced degradation of Met. Upper panels: HeLa cells were cultured in medium with or without HGF/SF and either lactacystin/ MG132 or concanamycin, as indicated. Lysates from cells harvested at the indicated times after HGF/SF addition were resolved by SDS ± PAGE and examined by Western analysis under reducing conditions using of a dominant negative form of dynamin (K44A), a GTPase that is required for vesicle ®ssion. Both treatments led to suppression of Met degradation. Using HeLa cells that have been engineered to express K44A dynamin under the control of a tetracycline switch, we have observed that the rate of Met degradation is signi®cantly decreased when endocytosis is impaired by mutant dynamin expression. Met degradation in this cell line (+Tet) displays partial sensitivity to lactacystin and to concanamycin. Following K44A dynamin expression (7Tet), the sensitivity to lactacystin of the Met degradation that does occur, is retained, whilst sensitivity to concanamycin is no longer apparent (Figure 4 ). These observations support the notion that Met degradation involves the cooperation between proteasomal and lysosomal pathways. However, they also indicate the existence of an alternative, slower, proteasomal degradation process that is independent of dynamin-dependent internalization and degradation by lysosomal enzymes. In normally functioning cells this will be a minor pathway. It is characterized by the production of a *100 kD intermediate recognized by an antibody against the extracellular domain of the b-chain, that we observe following HGF/SF stimulation of concanamycin-treated HeLa cells or cells expressing K44A dynamin. It is interesting to note that this fragment corresponds to the predicted size following loss of the entire cytoplasmic domain. Evidence in support of a minor lysosome-independent pathway is also provided by the failure of concanamycin to fully inhibit Met degradation (Figure 2) . At 1 h following stimulation about two-thirds of the Met degradation at that point is rescued by concanamycin, with this proportion decreasing at longer time points. Thus, in the absence of a concanamycin block, from simple kinetic considerations, more than two-thirds of the receptors will proceed by this lysosomal degradation pathway. We have developed an immuno¯uorescence approach which allows us to visualize Met internalization following HGF/SF stimulation. Without stimulation, Met is predominantly located at the plasma membrane, but following HGF/SF treatment the receptor is rapidly internalized to early endosomes ( Figure 5 ). At later time points the localization pattern is more perinuclear, typical of late endosomes/lysosomes. Remarkably, in distinction to transferrin receptor (TfR) and EGFR, treatment with lactacystin has a profound eect on Met receptor redistribution, apparently con®ning the receptor to the plasma membrane even in the presence of HGF/SF. This observation has great explanatory power: it allows us to reconcile how it is that the receptor degradation can be fully sensitive to proteasome inhibitors, yet also sensitive to inhibitors of lysosomal enzymes. The most simple explanation is that the lysosomal degradation pathway is the major route by which Met is degraded, but that proteasome activity is principally required for delivery of the receptor to late endosomal compartments rather than for degradation of Met per se. At this point we do not know if proteasome activity is required for the actual Met internalization step or, alternatively, if it is required to promote sorting of receptors into multivesicular bodies, at the expense of recycling to the plasma membrane. The molecular mechanisms of Met receptor downregulation must be distinct from a number of other RTKs, such as EGFR, c-kit receptor and PDGFbR, which are relatively insensitive to proteasome inhibitors across a variety of cell types (reviewed in Bonifacino and Weissman, 1998) . One attractive explanation is to postulate an additional factor, X, that speci®cally retains Met at the plasma membrane, but which is degraded by the proteasome following HGF/SF stimulation of Met. We note a striking similarity between our observations on Met down-regulation with those of Strous and co-workers who have been studying growth hormone receptor (GHR) down- Alexa Flour 594-coupled secondary antibody. Constellations or double labelled punctae bound by boxes are also shown at higher magni®cation. Arrows have been used to highlight additional examples of punctae associated with both labels Figure 6 Internalization of activated Met molecules is blocked by lactacystin. HeLa cells were stimulated for 1 h with either HGF/SF (a), EGF (100 ng/ml) (c), or biotinylated transferrin (25 mg/ml) (e) alone, or in conjunction with 10 mM lactacystin (b, d and f, respectively). Those cells treated with EGF or biotinylated transferrin were serum-starved overnight prior to the experiment. After the 1 h stimulation, the cells were washed, ®xed and then stained with the appropriate primary and uorescently-labelled secondary antibodies. Resultant¯uorescent labelling was visualized by con-focal microscopy as described in Materials and methods regulation (Govers et al., 1997 (Govers et al., , 1999 van Kerkhof et al., 2000) . In that case also, receptor degradation is lysosomal yet sensitive to proteasome inhibitors and also requires an intact ubiquitination system. In a series of elegant experiments they have established that although it occurs, direct ubiquitination of the receptor is not required for internalization or degradation. They have also shown that proteasome inhibition blocks endocytosis and receptor degradation (van Kerkhof et al., 2000) . A 10 amino acid Ube motif (ubiquitindependent endocytosis) in the cytosolic domain of the GHR regulates its ubiquitin-dependent endocytosis but this domain is absent in Met (Govers et al., 1999) .
It is clear that the ubiquitin-conjugating and proteasomal systems can regulate residence time of signalling receptors at the plasma membrane in a myriad of dierent ways. This complexity may have a positive side, in that it may indicate possible therapeutic opportunities to more speci®cally downregulate individual receptors.
Materials and methods
Cell culture
All cell culture reagents were obtained from Gibco. HeLa cells were incubated in a humidi®ed 5% CO 2 atmosphere, at 378C, in Dulbecco's modi®ed Eagle's medium (DMEM) supplemented with 10% heat-inactivated foetal bovine serum (FBS), 1% non-essential amino acids and 100 units/ml of both penicillin and streptamycin sulphate. K44A cells (generous gift of S Schmid) were cultured in HeLa medium supplemented with G418 (400 mg/ml), puromycin (200 ng/ml) and tetracycline (1 mg/ml). For induction of HA-tagged K44A mutant dynamin tetracycline was withdrawn for 48 h prior to the experiment. Expression of mutant dynamin was monitored by Western blotting and immuno¯uorescence. Typically, 595% of cells expressed the K44A mutant and the corresponding cells showed inhibition of biotinylated transferrin uptake as judged by labelling with streptavidin-Oregon Green 488.
Antibodies and other reagents
Puri®ed recombinant human HGF/SF was obtained from R&D Systems and also puri®ed from the supernatant of NIH3T3 cells engineered to overexpress the factor as previously described (Rong et al., 1993) . The preparation in each case consists of a mixture of predominantly single-chain inactive HGF/SF, as well as some heterodimeric HGF/SF. An extracellular serine protease is required to cleave the single-chain pro-peptide forming the biologically-active molecule. Previous studies have shown that the protease is produced either by the cells in culture, or is present in serum (Naldini et al., 1992 HGF/SF-stimulation and receptor down-regulation assay Cells were grown to approximately 60% con¯uence on 60 mm diameter tissue culture dishes and stimulated for various time periods with approximately 250 ng/ml HGF/SF. Where indicated, cells were pre-incubated for either 2 h with 10 mM lactacystin, 1 h with 20 mM MG132 or 30 min with 100 nM concanamycin. Inhibitors were also present throughout the period of HGF/SF stimulation in each case. Following HGF/SF stimulation, the cells were washed several times with cold PBS and lysed for 10 ± 15 min on ice in lysis buer (50 mM Tris/HCl pH 7.5, 150 mM NaCl, 5 mM EDTA, 0.3% (w/v) Triton X-100, supplemented with mammalian protease inhibitor cocktail [Sigma] ).
Western blotting
Lysates were pre-cleared by centrifugation and resolved by 8% sodium-dodecyl sulphate polyacrylamide gel electrophoresis (SDS ± PAGE). Following SDS ± PAGE, proteins were then transferred to nitrocellulose membrane (Schleicher and Schuell) which were then blocked for at least 1 h (at room temperature), or overnight (at 48C) by incubation in PBS containing 5% nonfat dry milk (blocking buer). Membranes were incubated with speci®c primary antibodies in blocking buer for at least 1 h (at room temperature) or overnight (at 48C). Unbound antibodies were removed by washing in blocking buer containing 0.05% Tween-20. Proteins were detected using horseradish peroxidase (HRP) conjugated secondary antibodies (1 h incubation at room temperature) via enhanced chemiluminescence (ECL) (Pierce Supersignal). Blots were routinely re-probed with anti-tubulin, to con®rm equal amounts of lysate protein had been loaded on gels. The paired t-test was used in all cases to assess the statistical signi®cance of quantitative data.
Immunofluorescence
HeLa cells grown on coverslips were ®xed immediately after each experiment with 3% paraformaldehyde (TAAB, UK) in PBS. Residual PBS was quenched with 50 mM NH 4 Cl/PBS and cells were then permeabilized with 0.2% (w/v) Triton X-100/ PBS and blocked with 10% goat serum in PBS. All antibody dilutions were in 5% goat serum/PBS and incubation times were 20 ± 30 min (60 min for anti-LBPA primary antibody [64C]). After extensive washing, coverslips were then mounted using Moviol and observed under a BioRad LaserSharp confocal microscope. Z-sections were taken at 260 nm intervals and analysed with the appropriate software.
